ARCH Venture Partners
ARCH Venture Partners is an early-stage venture firm that backs and builds companies based on life science discoveries and other disruptive technologies. It partners with scientists and entrepreneurs to develop technologies that can prevent, detect, and cure disease and improve people’s lives.
Facts
- HQ
- Chicago, IL, US
- Sectors
- Venture Capital and Private Equity Principals
- Founded
- 1986
- Employees
- 65
- Stage
- early-stage
Is this your organization? Claim it
Fast-growing biotech startup Cellares plans layoffs after losing major pharmaceutical customer
Biotech startup Cellares is planning layoffs after losing a major pharmaceutical customer, even though it had doubled its client base since early 2026.
Fierce Biotech Tracker: InduPro raises $77M Series B; Vaderis nets $152M Series B to advance cancer and rare-disease candidates
Fierce Biotech's fundraising tracker lists biotech venture rounds of $50M+ for August, highlighting InduPro's $77M Series B to advance its bispecific ADC IDP-001 into a phase 1 trial and Vaderis Therapeutics' $152M Series B to fund a phase 3 study of AKT inhibitor engasertib for hereditary hemorrhagic telangiectasia.
AlleyWatch lists 19 Biggest Global Startup Funding Rounds of July 2026, including a ¥50B Chinese AI raise and $1.4B German robotics deal
An AlleyWatch roundup, using CrunchBase data, lists the largest global startup funding rounds in July 2026, highlighting major multi‑hundred‑million and billion‑dollar investments across AI, robotics, nuclear fusion, quantum computing, and military AI.
See all 44 news stories about ARCH Venture Partners.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 22-
Keith Crandell Co-founder & Managing Director
-
Robert Nelsen Co-founder & Managing Director
-
Ari Nowacek Partner